The Market Reports

Synopsis
The global market for Phototherapy Treatment was estimated to be worth US$ 439 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Phototherapy treatment is a medical therapy that uses light to treat various health conditions, particularly skin disorders and certain types of jaundice. The therapy involves exposing the skin to ultraviolet (UV) light or visible light under controlled conditions, which can help in the treatment of conditions like psoriasis, eczema, vitiligo, and neonatal jaundice. Phototherapy can be administered through special lightboxes, lamps, or handheld devices. By penetrating the skin, the light helps to regulate the immune system, reduce inflammation, and promote the healing of skin cells. In the case of jaundice in newborns, phototherapy is used to break down excess bilirubin in the bloodstream, aiding in its removal and improving the infant’s condition.
The phototherapy treatment market is primarily driven by the increasing prevalence of skin disorders, such as psoriasis, eczema, and vitiligo, as well as the rising rates of neonatal jaundice, which necessitate effective treatments. The growing awareness of the benefits of light-based therapies and their non-invasive nature has also contributed to the market's expansion. Phototherapy is considered a safe and effective alternative to more aggressive treatments, such as systemic medications, and is gaining traction in both developed and emerging markets. Additionally, advancements in phototherapy devices, such as home-use phototherapy systems and portable light therapy units, are making treatment more accessible and convenient for patients, further fueling market growth.
However, the phototherapy treatment market faces several challenges, including the potential side effects of long-term UV exposure, such as skin aging and an increased risk of skin cancer. There are also concerns related to the cost of high-quality phototherapy devices, which can be prohibitively expensive for some patients, especially in low-income regions. Moreover, while phototherapy is effective for certain conditions, it may not be suitable for all patients, and the need for consistent treatment regimens can be a barrier for patient adherence. The market also faces regulatory hurdles in terms of device safety and efficacy, requiring manufacturers to comply with stringent medical standards and obtain necessary approvals.
Global key players of Phototherapy Treatment include GE Healthcare, Atom Medical, Draeger, Herbert Waldmann, Natus Medical, Daavlin, Beurer and National Biological, etc. Top three players occupy for a share about 19%. North America is the largest market, with a share about 31%, followed by Europe and Asia-Pacific. In terms of product, LED Phototherapy Treatment is the largest segment, with a share over 59%. In terms of application, Hospital and Clinic is the largest market, with a share over 84%.
This report aims to provide a comprehensive presentation of the global market for Phototherapy Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Phototherapy Treatment by region & country, by Type, and by Application.
The Phototherapy Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phototherapy Treatment.
Market Segmentation
By Company
GE Healthcare
Atom Medical
Draeger
Herbert Waldmann
Natus Medical
Daavlin
Beurer
National Biological
DAVID
Solarc Systems
UVBioTek
MTTS Asia
Nice Neotech
Segment by Type
Conventional
LED
Fiberoptic
Segment by Application
Hospital & Clinic
Home
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phototherapy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Phototherapy Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Phototherapy Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index